I dd mans spr (1975)

Сюжет кино: Список литературы
1. Wen Kesari S. N. Engl. J. Med. 2008; 359 (5): 492–507.
2. Hou Veeravagu Hsu Tse Neurosurg. Focus. 2006; 20 (4): 5.
3. Kohler Milstein C. Nature. 1975; 256 (5517): 495–497.
4. Modjtahedi Ali Essapen S. Br. Med. Bull. 2012; 104: 41–59.
5. Hwang Foote J. Methods. 2005; 36 (1): 3–10.
6. Lonberg N. Curr Opin Immunol. 2008; 20 (4): 450–459.
7. Gedeon Choi Hodges Mitchell Big-ner Sampson Exp. Rev. Clin. Pharmacol. 2013; 6 (4): 375–386.
8. Stockmeyer Elsasser Dechant Repp Gramatzki Glennie van de Winkel Valerius T. J. Imm. Methods. 2001; 248 (1–2): 103–111.
9. Schlachetzki Zhu Pardridge J. Neurochem. 2002; 81 (1): 203–206.
10. Roopenian Akilesh S. Nat. Rev. Immunol. 2007; 7 (9): 715–725.
11. Skerra Pluckthun A. Science. 1988; 240 (4855): 1038–1041.
12. Better Chang Robinson Horwitz Science. 1988; 240 (4855): 1041–1043.
13. Choi Cai Bigner Mehta Kuan Sampson Exp. Opin. Biol. Ther. 2011; 11 (7): 843–853.
14. De Jonge Brissinck Heirman Demanet Leo Mo-ser Thielemans K. Mol. Immunol. 1995; 32 (17–18): 1405–1412.
15. World Health Organization. Medicines. INN stems. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2013. URL: http://www. (аvailable: )
16. Chaudhry O’Donovan Brenchley Reid Rob-erts Histopathology. 2001; 39 (4): 409–415.
17. Alitalo Carmeliet P. Cancer Cell. 2002; 1 (3): 219–227.
18. Gururangan Chi Young Poussaint Onar–Thomas Gilbertson Vajapeyam Friedman Packer Rood Boyett Kun J. Clin. Oncol. 2010; 28 (18): 3069–3075.
19. Nghiemphu Liu Lee Than Graham Lai Green Pope Liau Mischel Nelson Elashoff Cloughesy Neurology. 2009; 72 (14): 1217–1222.
20. Imai Takaoka A. Nat. Rev. Cancer. 2006; 6 (9): 714–727.
21. Van Cutsem Nordlinger Cervantes A. Ann. Oncol. 2010; 21 (Suppl 5): 93–97.
22. Peters Adjei Gridelli Reck Kerr Felip E. Ann. Oncol. 2012; 23 (Suppl 7): 56–64.
23. Stupp Brada van den Bent Tonn Pentheroudakis G. Ann. Oncol. 2014. DOI:
24. Narita Jpn J. Clin. Oncol. 2013; 43 (6): 587–595.
25. Chamberlain Johnston J. Neurooncol. 2010; 96 (2): 259–269.
26. Nagane Nishikawa Narita Kobayashi Takano Shinoura Aoki Sugiyama Kuratsu Muragaki Sawamura Matsutani Jpn J. Clin. Oncol. 2012; 42 (10): 887–895.
27. Pope Lai Nghiemphu Mischel Cloughesy Neurology. 2006; 66 (8): 1258–1260.
28. Vredenburgh Desjardins Herndon Dowell Rear-don Quinn Rich Sathornsumetee Gururangan Wagner Bigner Friedman Friedman Clin. Cancer Res. 2007; 13 (4): 1253–1259.
29. Friedman Prados Wen Mikkelsen Schiff Abrey Yung Paleologos Nicholas Jensen Vredenburgh Huang Zheng Cloughesy T. J. Clin. Oncol. 2009; 27 (28): 4733–4740.
30. Kreisl Kim Moore Duic Royce Stroud Garren Mackey Butman Camphausen Park Albert Fine J. Clin. Oncol. 2009; 27 (5): 740–745.
31. Reardon Desjardins Vredenburgh Gururangan Sampson Sathornsumetee McLendon Herndon Marcello Norfleet Friedman Bigner Friedman Br. J. Cancer. 2009; 101 (12): 1986–1994.
32. Reardon Desjardins Peters Vredenburgh Guru-rangan Sampson McLendon Herndon Coan Threatt Friedman Friedman Cancer. 2011; 117 (23): 5351–5358.
33. Desjardins Reardon Coan Marcello Herndon Bailey Peters Friedman Vredenburgh Cancer. 2012; 118 (5): 1302–1312.
34. Quant Norden Drappatz Muzikansky Doherty Lafrankie Ciampa Kesari Wen Neuro Oncol. 2009; 11 (5): 550–555.
35. Norden Young Setayesh Muzikansky Klufas Ross Ciampa Ebbeling Levy Drappatz Kesari Wen Neurology. 2008; 70 (10): 779–787.
36. Wong Gautam Malchow Lun Pan Brem S. J. Nat. Compr. Canc. Netw. 2011; 9 (4): 403–407.
37. Seystahl Weller M. Exp. Opin. Investig Drugs. 2012; 21 (5): 605–617.
38. Wick Weller van den Bent Stupp R. J. Clin. Oncol. 2010; 28 (12): 188–189.
39. Boockvar Tsiouris Hofstetter Kovanlikaya Fralin Kesavabhotla Seedial Pannullo Schwartz Stieg Zimmerman Knopman Scheff Christos Vallabhajosula Riina J. Neurosurg. 2011; 114 (3): 624–632.
40. Burkhardt Riina Shin Christos Kesavabhotla Hofstetter Tsiouris Boockvar World Neurosurg. 2012; 77 (1): 130–134.
41. Vredenburgh Cloughesy Samant Prados Wen Mikkelsen Schiff Abrey Yung Paleologos Nicholas Jensen Das Friedman Oncologist. 2010; 15 (12): 1329–1334.
42. Iwamoto Abrey Beal Gutin Rosenblum Reuter DeAngelis Lassman Neurology. 2009; 73 (15): 1200–1206.
43. Wen Macdonald Reardon Cloughesy Sorensen Galanis Degroot Wick Gilbert Lassman Tsien Mikkelsen Wong Chamberlain Stupp Lamborn Vogelbaum van den Bent Chang J. Clin. Oncol. 2010; 28 (11): 1963–1972.
44. Zuniga Torcuator Jain Anderson Doyle Schultz Mikkelsen T. J. Neurooncol. 2010; 99 (2): 237–242.
45. Clark Lamborn Butowski Chang Prados Clarke McDermott Parsa Berger Aghi Neurosurgery. 2012; 70 (2): 361–370.
46. Lai Tran Nghiemphu Pope Solis Selch Filka Yong Mischel Liau Phuphanich Black Peak Green Spier Kolevska Polikoff Fehrenbacher Elashoff Cloughesy T. J. Clin. Oncol. 2011; 29 (2): 142–148.
47. Chinot de La Motte Rouge Moore Zeaiter Das Phillips Modrusan Cloughesy T. Adv. Ther. 2011; 28 (4): 334–340.
48. Gilbert Dignam Armstrong Wefel Blumenthal Vogelbaum Colman Chakravarti Pugh Won Jeraj Brown Jaeckle Schiff Stieber Brachman Werner-Wasik Tremont-Lukats Sulman Aldape Curran Mehta N. Engl. J. Med. 2014; 370 (8): 699–708.
49. Gilbert Sulman Mehta N. Engl. J. Med. 2014; 370 (21): 2048–2049.
50. Liguigli Tomasello Toppo Ratti Passalacqua R. Future Oncol. 2014; 10 (9): 1549–1557.
51. Корчагина А.А., Шеин С.А., Гурина О.И., Чехонин В.П. Роль рецепторов VEGFR в неопластическом ангиогенезе и перспективы терапии опухолей мозга. Вестник РАМН. 2013; 11: 104–114.
52. Ikeda Sun Tsuruoka Ishigaki Yoshitomi Yoshi-take Yonekura H. Biochem J. 2011; 436 (2): 399–407.
53. Heldin Westermark B. Physiol Rev. 1999; 79 (4): 1283–1316.
54. Dong Grunstein Tejada Peale Frantz Liang Bai Yu Kowalski Liang Fuh Gerber Ferrara N. Embo J. 2004; 23 (14): 2800–2810.
55. Fleming Saxena Clark Robertson Oldfield Aaronson Ali Cancer Res. 1992; 52 (16): 4550–4553.
56. Loizos Xu Huber Liu Lu Finnerty Rolser Malikzay Persaud Corcoran Deevi Balderes Bassi Jimenez Joynes Mangalampalli Steiner Tonra Wu Pereira Zhu Ludwig Hicklin Bohlen Witte Kussie P. Mol. Cancer Ther. 2005; 4 (3): 369–379.
57. Chiorean Sweeney Youssoufian Qin Dontabhaktuni Loizos Nippgen Amato R. Cancer Chem. Pharmacol. 2014; 73 (3): 595–604.
58. Hernandez-Pedro Rangel-Lopez Vargas Felix Pineda Sotelo J. Autoimmune Dis. 2013. DOI:
59. Blakeley Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme. Clinical Trials. gov: a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. URL: http:// (available:)
60. Gherardi Youles Miguel Blundell Iamele Gough Bandyopadhyay Hartmann Butler P. J. Proc. Natl. Acad. Sci USA. 2003; 100 (21): 12039–12044.
61. Koochekpour Jeffers Rulong Taylor Klineberg Hudson Resau Vande Woude Cancer Res. 1997; 57 (23): 5391–5398.
62. Cao Su Oskarsson Zhao Kort Fisher Wang Vande Woude Proc. Natl. Acad. Sci USA. 2001; 98 (13): 7443–7348.
63. Burgess Coxon Meyer Sun Rex Tsuruda Chen Ho Li Kaufman McDorman Cattley Elliott Zhang Feng Jia Green Radinsky Kendall R. Cancer Res. 2006; 66 (3): 1721–1729.
64. Buchanan Scott Tandle Burgan Burgess Tofilon Camphausen K. J. Cell. Mol. Med. 2011; 15 (9): 1999– 2006.
65. Jun Sun Rex Radinsky Kendall Coxon Burgess Clin. Cancer Res. 2007; 13 (22 Pt 1): 6735–6742.
66. Rex Lewis Gobalakrishnan Glaus Silva Radinsky Burgess Gambhir Coxon A. Nuc. Med. Biol. 2013; 40 (4): 458–463.
67. Wen Schiff Cloughesy Raizer Laterra Smitt Wolf Oliner Anderson Zhu Loh Reardon Neuro Oncol. 2011; 13 (4): 437–446.
68. Martens Schmidt Eckerich Fillbrandt Merchant Schwall Westphal Lamszus K. Clin. Cancer Res. 2006; 12 (20 Pt 1): 6144–6152.
69. Xin Jin Eppler Damico-Beyer Joshi Davis Kaur Nijem Bothos Peterson Patel Bai S. J. Clin. Pharmacol. 2013; 53 (11): 1103–1111.
70. Massague J. J. Biol. Chem. 1983; 258 (22): 13614–13620.
71. Kalman Szep Garzuly Post Neuromol. Med. 2013; 15 (2): 420–434.
72. Ullrich Coussens Hayflick Dull Gray Tam Lee Yarden Libermann Schlessinger J. et al. Nature. 1984; 309 (5967): 418–425.
73. Wells A. Int. J. Biochem. Cell. Biol. 1999; 31 (6): 637–643.
74. Ekstrand James Cavenee Seliger Petters-son Collins Cancer Res. 1991; 51 (8): 2164–2172.
75. Jaros Perry Adam Kelly Crawford Kal-bag Mendelow Sengupta Pearson Br. J. Cancer. 1992; 66 (2): 373–385.
76. Libermann Nusbaum Razon Kris Lax Soreq Whittle Waterfield Ullrich Schlessinger J. Nature. 1985; 313 (5998): 144–147.
77. Mineo Bordron Baroncini Maurage Ramirez Siminski Berthou Dam Hieu P. J. Neurooncol. 2007; 85 (3): 281–287.
78. Torp Gulati Johannessen Dalen A. J. Exp. Clin. Cancer Res. 2007; 26 (3): 353–359.
79. Sugawa Ekstrand James Collins Proc. Natl. Acad Sci USA. 1990; 87 (21): 8602–8606.
80. Boockvar Kapitonov Kapoor Schouten Counelis Bogler Snyder McIntosh O’Rourke Mol. Cell. Neurosci. 2003; 24 (4): 1116–1130.
81. Pedersen Tkach Pedersen Berezin Poulsen Int. J. Cancer. 2004; 108 (5): 643–653.
82. Montgomery Guzman O’Rourke Stahl J. Biol. Chem. 2000; 275 (23): 17358–17363.
83. Nagane Narita Mishima Levitzki Burgess Cavenee Huang J. Neurosurg. 2001; 95 (3): 472–479.
84. Inda Bonavia Mukasa Narita Sah Vanden-berg Brennan Johns Bachoo Hadwiger Tan Depinho Cavenee Furnari F. Genes Dev. 2010; 24 (16): 1731–1745.
85. Wikstrand McLendon Friedman Bigner Cancer Res. 1997; 57 (18): 4130–4140.
86. Del Vecchio Giacomini Vogel Jensen Florio Merlo Pollack Wong Oncogene. 2013; 32 (21): 2670–2681.
87. Humphrey Wong Vogelstein Zalutsky Fuller Archer Friedman Kwatra Bigner Bigner Proc. Natl. Acad. Sci USA. 1990; 87 (11): 4207–4211.
88. Eller Longo Kyle Bassano Hicklin Canute Neurosurgery. 2005; 56 (1): 155–162.
89. Patel Lahiji Patel Franklin Jimenez Hicklin Kang X. Anticancer Res. 2007; 27 (5a): 3355–3366.
90. Fukai Nishio Itakura Koizumi F. Cancer Sci. 2008; 99 (10): 2062–2069.
91. Taylor Furnari Cavenee Curr. Cancer Drug. Targets. 2012; 12 (3): 197–209.
92. Schulz-Ertner D. Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme (GERT). Clinical Trials. gov: a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. URL: show/NCT00311857?term=NCT00311857&rank=1 (available:)
93. Neyns Sadones Joosens Bouttens Verbeke Bau-rain D’Hondt Strauven Chaskis In’t Veld Michotte De Greve J. Ann. Oncol. 2009; 20 (9): 1596–1603.
94. Blesa Molla Esparcia Ortells Godoy Das Magan Pulla Sanchez Canales Candel Case Rep. Oncol. 2012; 5 (3): 676–681.
95. Hasselbalch Lassen Hansen Holmberg Sorensen Kosteljanetz Broholm Stockhausen Poulsen Neuro Oncol. 2010; 12 (5): 508–516.
96. Yi Hua Lin Kui Ning Wang J. Neurooncol. 2011; 104 (1): 93–101.
97. Bode Massimino Bach Zimmermann Khuhlaeva Westphal Fleischhack G. Exp. Opin. Biol. Ther. 2012; 12 (12): 1649–1659.
98. Ramos Figueredo Catala Gonzalez Selva Cruz Toledo Silva Pestano Ramos Leonard Torres Marinello Perez Lage A. Cancer Biol. Ther. 2006; 5 (4): 375–379.
99. Solomon Selva Figueredo Vaquer Toledo Quintanal Salva Domingez Alert Marinello Catala Griego Martell Luaces Ballesteros de Castro Bach Crombet T. BMC Cancer. 2013. DOI:
100. Jungbluth Stockert Huang Collins Coplan Iversen Kolb Johns Scott Gullick Ritter Cohen Scanlan Cavenee Old Proc. Natl. Acad. Sci USA. 2003; 100 (2): 639–644.
101. Johns McKay Cvrljevic Gan Taylor Xu Smyth Scott Int. J. Radiat. Oncol. Biol. Phys. 2010; 78 (2): 572–578.
102. Wang Shi Zhang Jiang Hu Kong Yao Yang Li Z. Faseb. J. 2012; 26 (1): 73–80.
103. Choi Kuan Cai Archer Mitchell Gedeon Sanchez-Perez Pastan Bigner Sampson Proc. Natl. Acad. Sci. USA. 2013; 110 (1): 270–275.
104. Chinot Wick Mason Henriksson Saran Nishikawa Carpentier Hoang-Xuan Kavan Cernea Brandes Hilton Abrey Cloughesy T. N. Engl. J. Med. 2014; 370 (8): 709–722.
105. Fine N. Engl. J. Med. 2014; 370 (8): 764–765.
106. De Bonis Lofrese Anile Pompucci Vigo Mangiola A. Immunotherapy. 2013; 5 (6): 647–659.
107. Chandramohan Sampson Pastan Bigner Clin. Dev. Immunol. 2012. DOI:
108. Chandramohan Bao Kato Kaneko Kato Keir Szafranski Kuan Pastan Bigner Int. J. Cancer. 2013; 132 (10): 2339–2348.
109. Piao Kuan Chandramohan Keir Pegram Bao Mansson Pastan Bigner MAbs. 2013; 5 (5): 748–762.
110. Wang Ni Lin Yin Jiang Lv Le Lang Zhao Yang Jiao Yin J. Tumour Biol. 2014; 35 (2): 1157–1168.
111. Chen Miao Tang Zhang Wang Luo Yan J. J. Biomed. Nanotechnol. 2013; 9 (4): 551–558.
112. Hulper Schulz-Schaeffer Dullin Hoffmann Harper Kurtzberg Lonning Kugler Lakomek Erdlenbruch B. Int. J. Oncol. 2011; 38 (1): 51–59.
113. Xiong Zhou Lim Yang Zhu Li Zhou Xiao Zhou Oncol. Rep. 2013; 30 (6): 2719–2724.
114. Zhu Fujita Snyder Okada H. J. Neurooncol. 2011; 104 (1): 83–92.
115. Sampson Schmittling Archer Congdon Nair Reap Desjardins Friedman Fried-man Herndon 2nd, Coan McLendon Rear-don Vredenburgh Bigner Mitchell PLoS One. 2012. DOI:
116. Kudo Jono Shinriki Yano Nakamura Makino Hide Muta Ueda Ota Ando Kuratsu J. J. Neurosurg. 2009; 111 (2): 219–225.
117. Cheng Zhou Wang Xie Wu Liu Wang Chen Hu Lu Zhang X. Hybridoma (Larchmt). 2009; 28 (1): 33–41.
118. Weber Osl Renner Poschinger Galban Rehemtulla Scheuer W. Cancer Res. 2014; 74 (7): 1913–1923.
119. Herrmann Grosse–Hovest Otz Krammer Rammensee Jung G. Cancer Res. 2008; 68 (4): 1221–1227.
120. Emlet Gupta Holgado-Madruga Del Vecchio Mitra Han Li Jensen Vogel Xu Skirboll Wong Cancer Res. 2014; 74 (4): 1238–1249.
121. Lou Wang Yeh Chuang Li Wu Khoo Hsiao Hsu Wong Proc. Natl. Acad. Sci USA. 2014; 111 (7): 2482–2487.
122. Zhan Yue Shaoshan H. Braz. J. Med. Biol. Res. 2011; 44 (5): 489–490.
123. Carbonell DeLay Jahangiri Park Aghi Cancer Res. 2013; 73 (10): 3145–3154.
124. Yoshida Matsuda Naito Ishiwata T. Pathol. Int. 2012; 62 (7): 463–470.
125. Poli Wang Domingues Planaguma Yan Rygh Skaftnesmo Thorsen McCormack Hentges Pedersen Zimmer Enger Chekenya M. Oncotarget. 2013; 4 (9): 1527–1546.
126. Matsutani Hiwasa Takiguchi Oide Kunimatsu Saeki Iwadate Y. J. Exp. Clin. Cancer Res. 2012. DOI:
127. Zheng Chang Zhang Rothman Tuszynski Exp. Mol. Pathol. 2012; 93 (1): 111–115.
128. Day Stringer Al–Ejeh Ting Wilson Ens-bey Jamieson Bruce Lim Offenhauser Charmsaz Cooper Ellacott Harding Leveque Inglis Allan Walker Lackmann Osborne Khanna Reynolds Lickliter Boyd Cancer Cell. 2013; 23 (2): 238–248.
129. Rogers Le Sather Pernu Graham Pierce Keating Oncogene. 2012; 31 (38): 4171–4181.
130. Foehr Lorente Kuo Ram Nikolich Urfer R. Cancer Res. 2006; 66 (4): 2271–2278.
131. Loftus Yang Tran Kloss Viso Berens Lipinski Mol. Cancer Ther. 2009; 8 (6): 1505–1514.
132. He Yin Luster Watkins Thorpe Clin. Cancer Res. 2009; 15 (22): 6871–6880.
133. Liang Piao Holmes Fuller Henry Tiao de Groot Clin. Cancer Res. 2014; 20 (1): 187–198.
134. Kato Kaneko Ogasawara Kato Tohoku J. Exp. Med. 2013; 230 (2): 103–109.
135. McIntyre Patiar Wigfield Li Ledaki Turley
136. Leek Snell Gatter Sly Vaughan-Jones Swietach Harris Clin. Cancer Res. 2012; 18 (11): 3100–3111.
137. Shao Francescone Ngernyuang Bentley Taylor Moral Yan W. Carcinogenesis. 2014; 35 (2): 373–382.
138. Areshkov Avdieiev Balynska Leroith Kavsan Int. J. Biol. Sci. 2012; 8 (1): 39–48.
139. Flies Han Higuchi Zheng Sun Ye Chen L. J. Clin. Invest. 2014; 124 (5): 1966–1975.
140. Newcomb Lukyanov Kawashima Alonso-Basanta Wang Liu Jure-Kunkel Zag-zag Demaria Formenti Radiat. Res. 2010; 173 (4): 426–432.
141. Fecci Ochiai Mitchell Grossi Sweeney Archer Cummings Allison Bigner Samp-son Clin. Cancer Res. 2007; 13 (7): 2158–2167.
142. Yusubalieva Baklaushev Gurina Gulyaev Pirogov Chekhonin Bull. Exp. Biol. Med. 2012; 153 (1): 163–169.
143. Yusubalieva Baklaushev Gurina Zorkina Gubskii Kobyakov Golanov Goryainov Gorlachev Konovalov Potapov Chekhonin Bull. Exp. Biol. Med. 2014; 157 (4): 510–115.